<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="104339">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02086461</url>
  </required_header>
  <id_info>
    <org_study_id>2013/896-31/4</org_study_id>
    <secondary_id>2013/896-31/4</secondary_id>
    <nct_id>NCT02086461</nct_id>
  </id_info>
  <brief_title>Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital Stay</brief_title>
  <official_title>Pylorus Dysfunction After Esophagectomy. Effect of Pneumatic Dilatation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Ã–rebro</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Akademiska Uppsala</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <authority>Sweden: Regional Ethical Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Delayed emptying of the gastric tube after esophagectomy is a frequent and durable problem.
      No treatment is currently available. It can be hypothesized that incomplete relaxation of
      the pyloric sphincter may be a significant contributing factor. Pneumatic dilatation may
      therefore be a potentially effective treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients surviving one year after esophagectomy are sent questionnaires to pick up symptoms
      suggestive of delayed gastric emptying.Those fulfilling predefined criteria for delayed
      gastric emptying will be invited to the study. The study design is sham controlled single
      blind with a follow up extending to twelve months post treatment.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Symptoms suggestive of delayed gastric emptying</measure>
    <time_frame>3-12 months after treatment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Symptoms will be assessed at 3, 6 and 12 months after therapy. In case of failure the code will be broken and if sham procedure has been done the patient will be offered pneumatic dilatation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>3-12 months after treatment.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Symptoms will be assessed at 3, 6 and 12 months after therapy. In case of failure the code will be broken and if sham procedure has been done the patient will be offered pneumatic dilatation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delayed gastric emptying</measure>
    <time_frame>3, 6 and 12 months after treatment.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Symptoms will be assessed at 3, 6 and 12 months after therapy. In case of failure the code will be broken and if sham procedure has been done the patient will be offered pneumatic dilatation. Paracetamol  test done only 3 months after treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Esophagectomy</condition>
  <condition>No Signs of Cancer Recurrence</condition>
  <condition>Delayed Gastric Emptying</condition>
  <arm_group>
    <arm_group_label>15 mm Pyloric balloon dilatation.</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>During fluoroscopic control the pneumatic balloon is positioned of the pyloric sphincter and maintained there during the entire dilatation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pneumatic pyloric dilatation.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endoscopy and 15 mm balloon dilatation is completed according to the same principle as active comparator arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pneumatic pyloric dilatation</intervention_name>
    <arm_group_label>Pneumatic pyloric dilatation.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>15 mm pyloric balloon dilatation</intervention_name>
    <arm_group_label>15 mm Pyloric balloon dilatation.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previous esophagectomy and gastric tube reconstruction.

          -  Symptoms suggestive of delayed gastric emptying.

          -  signed informed consent

        Exclusion Criteria:

          -  Signs of recurrent cancer disease

          -  no symptoms suggestive of delayed gastric emptying.

          -  unwillingness to participate
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jon Tsai, ass professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital, Gastrocentrum</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jon Tsai, Associate professor</last_name>
    <phone>0046736995364</phone>
    <email>jon.tsai@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lars Lundell, Professor</last_name>
    <phone>0046858500000</phone>
    <email>lars.lundell@karolinska.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jon Tsai, Ass Professor</last_name>
      <phone>0046858582307</phone>
      <email>jon.tsai@ki.se</email>
    </contact>
    <contact_backup>
      <last_name>Lars Lundell, Professor</last_name>
      <phone>00468585800000</phone>
      <email>lars.lundell@karolinska.se</email>
    </contact_backup>
    <investigator>
      <last_name>Jon Tsai, Ass Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>lars Lundell, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 12, 2014</lastchanged_date>
  <firstreceived_date>March 11, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Lars Lundell</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
